Active Pharmaceutical Ingredient (API)
Entacapone
COMT Inhibitor (Parkinson’s Adjunct)
A Catechol-O-Methyltransferase ($\text{COMT}$) inhibitor used as an adjunctive therapy with Levodopa/Carbidopa for Parkinson's disease. By blocking the $\text{COMT}$ enzyme, it prevents the peripheral breakdown of Levodopa, increasing its bioavailability and sustained concentration in the brain, thereby prolonging its therapeutic effect.
Technical Profile
- Reference Code
- ENT234
- CAS Number
- 130929-57-6
- Molecular Weight
- 305.29 g/mol
- Chemical Class
- N/A
- Molecular Formula
- C14H15N3O5
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Entacapone as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||